PricingSimple, transparent
Simple, transparent
pay-per-compound pricing
No subscriptions. No seat licences. Pay only for the compounds you screen — with all 55+ ADMET models and QMRF documentation included in every purchase.
Free Trial — 2 compounds, limited endpoint selection
Start Free Trial No credit card required. Start screening immediately.
Pay-per-compound packages
All packages include the full endpoint set and QMRF documentation.
1 compound
$150
$150/compound
3 compounds
$390
$130/compound
Save 13%
10 compounds
$1000
$100/compound
Save 33%
Everything included in every purchase
One price, the complete picture.
Included
All 55+ ADMET models
Human Carcinogenic Risk Score
QMRF documentation for every assay
OECD-compliant predictions
Read-across analysis (3 closest analogues)
Structural alerts highlighted for genotoxicity endpoints
Downloadable PDF report
Full SMILES input support
Not included (add-ons)
Expert written interpretation (add-on)
Volume / enterprise pricing (contact us)
Free trial vs. full purchase
The free trial lets you experience the platform before committing.
| Feature | Free Trial | Full Purchase |
|---|---|---|
| Available Endpoints | 5 | 35 |
| Compound count | 2 | Unlimited |
| QMRF documentation | ||
| OECD-compliant predictions | ||
| Read-across analysis | ||
| Risk Score ranking | ||
| Signing an NDA | ||
| PDF report | ||
| Regulatory use |
Enterprise & Volume
Screening hundreds of compounds?
Custom volume pricing, NDA agreements, and dedicated data handling for large-scale screening campaigns. Enterprise packages are available for pharma teams, CROs, and research institutions.
Custom volume pricing
NDA & data confidentiality agreements
Priority support & onboarding
API access (for CRO integrations)
Contact for enterprise pricing
We typically respond within 1 business day.
“A failed in vivo safety study costs $500k–$2M. Catching that compound in silico at $150 is not a cost — it’s an insurance policy.”